Celsius vs. Colgate-Palmolive: Which Consumer Goods Stock Is a Better Buy for 2027?
Celsius's hyper-growth and Pepsi partnership square off against Colgate-Palmolive's steady cash flow and defensive brands, and the answer depends on how much risk you can handle.
When weighing the prospects of investing in Celsius or Colgate-Palmolive for the year 2027, one must consider their respective business models, growth potential, and risk factors. Celsius, a high-growth player in the functional energy drinks market, experiences rapid revenue expansion, largely driven by its partnership with PepsiCo.
Yet, this concentration of sales poses significant risk due to potential conflicts with its key distributor. The company operates with a conservative debt-to-equity ratio of 0.2x and maintains healthy free cash flow at nearly $323.4 million. On the other hand, Colgate-Palmolive, a stalwart in consumer staples, benefits from a diverse portfolio of brands spanning oral care, personal hygiene, and pet nutrition.
Its strong global presence, anchored by the Walmart partnership, and continuous innovation in branding efforts provide a robust revenue base. However, the company faces challenges such as foreign currency fluctuations, geopolitical risks, and legal liabilities, with a notably higher debt-to-equity ratio of 158.4x. Despite these challenges, Colgate's long-standing dividend growth and diverse product offerings make it a dependable choice.
Given its consistent performance, dividend history, and overall market positioning, Colgate-Palmolive emerges as the more robust option for investors targeting long-term stability and growth in 2027.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
